RxDoctor Payments Data

Sue Ming, MD

Neurology · Edison, NJNPI 1346314507

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,709 of the $6,990 with a category attached, or 81.7%. Amicus Therapeutics, Inc. accounts for 81.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $5,857 and has fallen 94.4% since, to $328 in 2025.

$6,990in general payments, 2019–2025

Across 9 payments — averaging $776.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amicus Therapeutics, Inc.$6K
  • Sanofi$550
  • Medtronic$463
  • Jazz Pharmaceuticals Inc.$149
  • Boehringer Ingelheim$120
$241,449in research payments, 2019–2025

Across 31 payments — averaging $7788.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amicus Therapeutics, Inc.$141K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$100K

What the payments were for

  • Consulting fees$5,70982%
  • Speaking & faculty fees$5508%
  • Food & beverage$73210%

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,990 in reported general payments places this provider in the 65th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey

Medicare billing

Part B allowed, 2024
$7,158
Medicare patients
54
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Edison

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →